Clinical Pharmacology Study of MRA in Patient With Rheumatoid Arthritis (RA) With Renal Impairment

Sponsor
Chugai Pharmaceutical
Study ID
NCT00144573
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
20 Years - 75 Years
Healthy Volunteers
Not accepted

Interventions

Study Details

This is an open-label, clinical pharmacology study to evaluate the safety and PK of MRA in patients with RA with Renal Impairment.

Key Dates

Start date
Jan 31, 2005
Status verified
Dec 2008
Primary completion
Oct 31, 2005
Completion
Oct 31, 2005

Study Design

Enrollment
14 participants (actual)
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Primary Outcome Measure

20% improvement based on the ACR criteria compared with the baseline value. [ Time Frame: throughout study ]

Related Studies